Adela Dashian, an analyst from Jefferies, maintained the Buy rating on Swedencare AB. The associated price target remains the same with SEK60.00.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Adela Dashian’s rating is based on several compelling factors that suggest potential upside for Swedencare AB despite recent performance challenges. The company has reiterated its full-year guidance for achieving double-digit organic growth and improved profitability, which indicates management’s confidence in overcoming current hurdles. Additionally, the stock’s current price presents a 25% upside potential to the price target of SEK 60.00, making it an attractive investment opportunity.
While Swedencare has faced setbacks such as the delayed Walmart order and transition issues with NaturVet’s Amazon account, these are seen as temporary challenges. The company’s ability to maintain a positive year-over-year growth in net revenue and a significant increase in the Treats segment demonstrates underlying business strength. Adela Dashian believes that the market may be undervaluing Swedencare’s long-term prospects, thus justifying the Buy rating.
Dashian covers the Consumer Cyclical sector, focusing on stocks such as Thule Group AB, MIPS AB, and Tomra Systems ASA. According to TipRanks, Dashian has an average return of 10.4% and a 57.14% success rate on recommended stocks.
In another report released on July 9, TR | OpenAI – 4o also upgraded the stock to a Buy with a SEK52.00 price target.